Short answer · Medically reviewed summary · Last updated: 2026-04-07
Beckwith-Wiedemann syndrome (BWS) is estimated to occur in approximately 1 in 10,340 to 1 in 13,700 live births worldwide. While it is classified as a rare overgrowth disorder, the true prevalence of Beckwith-Wiedemann syndrome is likely higher due to mild cases that go undiagnosed or are only identified later in life. Is Beckwith-Wiedemann syndrome considered a rare disease? Yes, Beckwith-Wiedemann syndrome is officially classified as a rare disease.
What is the prevalence of Beckwith-Wiedemann Syndrome?
Prevalence of Beckwith-Wiedemann Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Beckwith-Wiedemann syndrome (BWS) is estimated to occur in approximately 1 in 10,340 to 1 in 13,700 live births worldwide. While it is classified as a rare overgrowth disorder, the true prevalence of Beckwith-Wiedemann syndrome is likely higher due to mild cases that go undiagnosed or are only identified later in life.
Is Beckwith-Wiedemann syndrome considered a rare disease?
Yes, Beckwith-Wiedemann syndrome is officially classified as a rare disease. Because it is a spectrum disorder—meaning the severity of clinical features varies significantly between individuals—many people with milder presentations may never receive a formal diagnosis. At DiseaseMaps.org, we have seen 241 members join our community to share their experiences, which highlights that while the condition is rare, there is a vital, active network of families navigating these challenges together.
What are the known prevalence and incidence statistics?
Epidemiological data for Beckwith-Wiedemann syndrome suggests a relatively consistent global occurrence, though precise numbers are difficult to track due to the lack of a universal registry. Key statistical observations include:
- Estimated Incidence: Most clinical literature, including data from the NIH Genetic and Rare Diseases Information Center (GARD), places the incidence at roughly 1 in 10,000 to 1 in 15,000 births.
- Gender Distribution: There is no significant difference in the prevalence of Beckwith-Wiedemann syndrome between males and females; it affects both sexes equally.
- Geographic and Ethnic Variation: There is currently no evidence to suggest that Beckwith-Wiedemann syndrome is more prevalent in any specific ethnic group or geographic region.
At what age is the syndrome typically identified?
Beckwith-Wiedemann syndrome is primarily a pediatric diagnosis. Most individuals are identified at birth or in early infancy due to characteristic physical features such as macroglossia (enlarged tongue), abdominal wall defects (like omphalocele or umbilical hernia), and macrosomia (overgrowth). However, because some clinical features become less pronounced as a child grows, adults who were never diagnosed in childhood may remain unaware of their condition unless they undergo genetic testing for other health reasons.
Why is it difficult to determine the exact prevalence of Beckwith-Wiedemann syndrome?
Accurately measuring the prevalence of Beckwith-Wiedemann syndrome presents several clinical challenges:
- Clinical Heterogeneity: The molecular causes of the syndrome are diverse, involving epigenetic and genetic changes on chromosome 11p15.5. Some individuals have very subtle physical traits that do not prompt clinical suspicion.
- Diagnostic Evolution: As genetic testing technology improves, we are identifying more cases that would have been missed in previous decades.
- Reporting Gaps: Many rare disease registries rely on voluntary reporting, meaning that individuals with mild symptoms who do not require intensive medical intervention are often absent from official statistics.
Next steps
- Consult with a clinical geneticist to discuss whether molecular testing is appropriate if you suspect an undiagnosed case.
- If you are a parent or patient, consider joining the community at DiseaseMaps.org to connect with the 241+ members who share similar experiences.
- Ensure that individuals with a diagnosis are followed by a multidisciplinary team, including a pediatric oncologist or geneticist, for appropriate tumor surveillance.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Beckwith-Wiedemann syndrome overview.
- Orphanet: Prevalence and epidemiology of rare overgrowth syndromes.
- OMIM (Online Mendelian Inheritance in Man): Beckwith-Wiedemann syndrome (Entry #130650).
- DiseaseMaps.org: Community data and patient experience metrics.
